Biomarkers for detection of lung cancer

Victoria El Khoury (Inventor), Anna Schritz (Inventor), Yeoun Jin Kim (Inventor), Guy Berchem (Inventor), Amanda G. Paulovich (Inventor), Jeffrey R. Whiteaker (Inventor), Konstantinos Petritis (Inventor), Patrick Pirrotte (Inventor)

Research output: Patent


The application discloses in vitro methods for diagnosing lung cancer in a subject, wherein the method comprises detecting at least one biomarker selected from the group consisting of Rho GDP
dissociation inhibitor beta (ARHGDIB), alpha-tubulin 4A (TUBA4A), glutathione S-transferase
omega 1 (GSTO1), filamin A (FLNA), peroxiredoxin 6 (PRDX6) and cadherin 13 (CDH13) in a
biological sample from the subject, and kits for measuring said at least one biomarker.
Original languageEnglish
IPCWO 2021/219696
Publication statusPublished - 4 Nov 2021


Dive into the research topics of 'Biomarkers for detection of lung cancer'. Together they form a unique fingerprint.

Cite this